First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: A United Kingdom population-based cohort study

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Ban, Lu ^a   West, Joe ^a   Gibson, Jack E ^a   Fiaschi, Linda ^a   Sokal, Rachel ^a   Doyle, Pat ^b   Hubbard, Richard ^a   Smeeth, Liam ^b   Tata, Laila J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; TEMAZEPAM; ZOPICLONE; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; HYPNOTIC SEDATIVE AGENT;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; BODY MASS; CHILD; COHORT ANALYSIS; CONGENITAL MALFORMATION; CONTROLLED STUDY; DEPRESSION; DRUG SAFETY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; POPULATION BASED CASE CONTROL STUDY; PRENATAL EXPOSURE; PREVALENCE; PSYCHIATRIC DIAGNOSIS; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SMOKING; SOCIAL STATUS; UNITED KINGDOM; ABNORMALITIES, DRUG-INDUCED; ANXIETY; COMPLICATION; FOLLOW UP; GREAT BRITAIN; MALE; MIDDLE AGED; NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS; YOUNG ADULT;

ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; ADULT; ANTI-ANXIETY AGENTS; ANXIETY; BENZODIAZEPINES; CHILD; COHORT STUDIES; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; HYPNOTICS AND SEDATIVES; INFANT, NEWBORN; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PROGNOSIS; YOUNG ADULT;

EID: 84903544601     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100996     Document Type: Article

References (46)

1. Murray CJ, Richards MA, Newton JN, Fenton KA, Anderson HR, et al. (2013) UK health performance: findings of the Global Burden of Disease Study 2010. The Lancet. Available: http://linkinghub.elsevier.com/retrieve/pii/ S0140673613603554. Accessed 2013 Mar 8.
2. World Health Organisation (2001) Gender disparities in mental health. Available: http://www.who.int/mental-health/prevention/genderwomen/en/. Accessed 2013 May 18.
3. Ban L, Tata LJ, West J, Fiaschi L, Gibson JE (2012) Live and non-live pregnancy outcomes among women with depression and anxiety: A population-based study. PLoS ONE 7: e43462. doi:10.1371/journal.pone.0043462.
4. Marchetti F, Romero M, Bonati M, Tognoni G (1993) Use of psychotropic drugs during pregnancy. Eur J Clin Pharmacol 45: 495-501. doi:10.1007/ BF00315304.
5. D'Amato RJ, Loughnan MS, Flynn E, Folkman J (1994) Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A 91: 4082-4085. (Pubitemid 24139577)
6. National Institute for Health and Clinical Excellence (2007) Antenatal and postnatal mental health. Available: http://guidance.nice.org.uk/CG45. Accessed 2011 June 14.
7. Oyebode F, Rastogi A, Berrisford G, Coccia F (2012) Psychotropics in pregnancy: safety and other considerations. Pharmacol Ther 135: 71-77. doi:10.1016/j.pharmthera.2012.03.008.
8. Bellantuono C, Tofani S, Di Sciascio G, Santone G (2013) Benzodiazepine exposure in pregnancy and risk of major malformations: a critical overview. Gen Hosp Psychiatry 35: 3-8. doi:10.1016/j.genhosppsych.2012.09.003.
9. Enato E, Moretti M, Koren G (2011) The fetal safety of benzodiazepines: an updated meta-analysis. J Obstet Gynaecol Can JOGC J Obstétrique Gynécologie Can JOGC 33: 46-48.
10. Wikner BN, Stiller C, Bergman U, Asker C, Källén B (2007) Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Pharmacoepidemiol Drug Saf 16: 1203-1210. doi:10.1002/pds.1457. (Pubitemid 350120645)
11. Oberlander TF, Warburton W, Misri S, Riggs W, Aghajanian J, et al. (2008) Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. Birth Defects Res B Dev Reprod Toxicol 83: 68-76. doi:10.1002/bdrb.20144. (Pubitemid 351317794)
12. Wikner BN, Källén B (2011) Are hypnotic benzodiazepine receptor agonists teratogenic in humans?: J Clin Psychopharmacol 31: 356-359. doi:10.1097/JCP.0b013e3182197055.
13. Saxén I (1975) Associations between oral clefts and drugs taken during pregnancy. Int J Epidemiol 4: 37-44. doi:10.1093/ije/4.1.37.
14. Safra MJ, Oakley GP Jr (1975) Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 2: 478-480.
15. Cates C (1999) Benzodiazepine use in pregnancy and major malformations or oral clefts. Pooled results are sensitive to zero transformation used. BMJ 319: 918-919.
16. Czeizel A (1987) Lack of evidence of teratogenicity of benzodiazepine drugs in Hungary. Reprod Toxicol Elmsford N 1: 183-188.
17. Rosenberg L, Mitchell AA, Parsells JL, Pashayan H, Louik C, et al. (1983) Lack of relation of oral clefts to diazepam use during pregnancy. N Engl J Med 309: 1282-1285. doi:10.1056/NEJM198311243092103. (Pubitemid 14201583)
18. Czeizel A, Rockenbauer M, Sørensen H, Olsen J (2004) A population-based case - control study of oral chlordiazepoxide use during pregnancy and risk of congenital abnormalities. Neurotoxicol Teratol 26: 593-598. doi:10.1016/j.ntt.2004.03.009. (Pubitemid 38765181)
19. Correa-Villaseñor A, Ferencz C, Neill CA, Wilson PD, Boughman JA (1994) Ebstein's malformation of the tricuspid valve: genetic and environmental factors. The Baltimore-Washington Infant Study Group. Teratology 50: 137-147. doi:10.1002/tera.1420500208. (Pubitemid 24289115)
20. Tikkanen J, Heinonen OP (1992) Congenital heart disease in the offspring and maternal habits and home exposures during pregnancy. Teratology 46: 447-454. doi:10.1002/tera.1420460509.
21. Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL (2007) Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 16: 393-401. doi:10.1002/pds.1335. (Pubitemid 46656860)
22. Borthen I, Gilhus NE (2012) Pregnancy complications in patients with epilepsy. Curr Opin Obstet Gynecol 24: 78-83. doi:10.1097/GCO.0b013e32834feb6a.
23. Bodén R, Lundgren M, Brandt L, Reutfors J, Kieler H (2012) Antipsychotics during pregnancy: Relation to fetal and maternal metabolic effects. Arch Gen Psychiatry 69: 715-721. doi:10.1001/archgenpsychiatry.2011. 1870.
24. Bodén R, Lundgren M, Brandt L, Reutfors J, Andersen M, et al. (2012) Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study. BMJ 345: e7085-e7085. doi:10.1136/bmj.e7085.
25. Dolk H (2005) EUROCAT: 25 years of European surveillance of congenital anomalies. Arch Dis Child Fetal Neonatal Ed 90: F355-F358. doi:10.1136/adc.2004. 062810.
26. Sokal R, Fleming KM, Tata LJ (2013) Potential of general practice data for congenital anomaly research: comparison with registry data in the United Kingdom. Birt Defects Res A Clin Mol Teratol 97: 546-553. doi:10.1002/bdra. 23150.
27. Charlton RA, Weil JG, Cunnington MC, de Vries CS (2010) Identifying major congenital malformations in the UK General Practice Research Database (GPRD): a study reporting on the sensitivity and added value of photocopied medical records and free text in the GPRD. Drug Saf Int J Med Toxicol Drug Exp 33: 741-750. doi:10.2165/11536820-000000000-00000.
28. Wurst KE, Ephross SA, Loehr J, Clark DW, Guess HA (2007) Evaluation of the general practice research database congenital heart defects prevalence: Comparison to United Kingdom national systems. Birt Defects Res A Clin Mol Teratol 79: 309-316.
29. Wurst KE, Ephross SA, Loehr J, Clark DW, Guess HA (2007) The utility of the general practice research database to examine selected congenital heart defects: a validation study. Pharmacoepidemiol Drug Saf 16: 867-877. doi:10.1002/pds.1431. (Pubitemid 47322586)
30. Devine S, West SL, Andrews E, Tennis P, Eaton S, et al. (2008) Validation of neural tube defects in the full featured - general practice research database. Pharmacoepidemiol Drug Saf 17: 434-444. doi:10.1002/pds.1573. (Pubitemid 351722029)
31. Charlton RA, Cunnington MC, de Vries CS, Weil JG (2008) Data resources for investigating drug exposure during pregnancy and associated outcomes: The General Practice Research Database (GPRD) as an alternative to pregnancy registries. Drug Saf 31: 39-51.
32. Charlton RA, Weil JG, Cunnington MC, Ray S, de Vries CS (2011) Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as Tools for Postmarketing Teratogen Surveillance. Drug Saf 34: 157-171. doi:10.2165/11584970-000000000-00000.
33. Ban L, Gibson JE, West J, Fiaschi L, Oates MR, et al. (2012) Impact of socioeconomic deprivation on maternal perinatal mental illnesses presenting to UK general practice. Br J Gen Pract 62: e671-e678. doi:10.3399/bjgp12X656801.
34. Joint Formulary Committee (2012) British National Formulary (BNF) 63. 63rd Revised edition. Pharmaceutical Press. 1104 p.
35. Townsend P, Phillimore P, Beattie A (1988) Health and deprivation: Inequality and the North. Croom Helm. 250 p.
36. Dhalwani NN, Tata LJ, Coleman T, Fleming KM, Szatkowski L (2013) Completeness of maternal smoking status recording during pregnancy in United Kingdom primary care data. PLoS ONE 8: e72218. doi:10.1371/journal.pone.0072218.
37. Szatkowski L, Lewis S, McNeill A, Huang Y, Coleman T (2012) Can data from primary care medical records be used to monitor national smoking prevalence? J Epidemiol Community Health 66: 791-795. doi:10.1136/jech.2010.120154.
38. World Health Organization (n.d.) BMI classification. Available: http://apps.who.int/bmi/index.jsp?introPage = intro-3.html. Accessed 2014 Jan 9.
39. StataCorp (n.d.) Generalized estimating equations: xtgee. Available: http://www.stata.com/capabilities/generalized-estimating-equations/. Accessed 2012 May 30.
40. Prajapati B, Dunne M, Armstrong R (2010) Sample size estimation and statistical power analyses. Optom Today. Available: http://www.optometry.co.uk/ clinical/details?aid = 634. Accessed 2012 May 10.
41. Say L, Donner A, Gülmezoglu AM, Taljaard M, Piaggio G (2006) The prevalence of stillbirths: a systematic review. Reprod Health 3: 1. doi:10.1186/1742-4755-3-1.
42. The Stillbirth Collaborative Research Network (2011) Causes of death among stillbirths. JAMA 306: 2459-2468. doi:10.1001/jama.2011.1823.
43. Confidential Enquiry into Maternal and Child Health (CEMACH) (n.d.) Perinatal Mortality 2007: United Kingdom. Available: http://www.hqip.org.uk/ assets/NCAPOP-Library/CMACE-Reports/37.-June-2009-Perinatal-Mortality-2007.pdf. Accessed 2012 Feb 10.
44. Jueckstock JK, Kaestner R, Mylonas I (2010) Managing hyperemesis gravidarum: a multimodal challenge. BMC Med 8: 46. doi:10.1186/1741-7015-8-46.
45. Czeizel AE, Erös E, Rockenbauer M, Sørensen HT, Olsen J (2003) Short-term oral diazepam treatment during pregnancy: a population-based teratological case-control study. Clin Drug Investig 23: 451-462. (Pubitemid 36920517)
46. Kjær D, Horvath-Puhó E, Christensen J, Vestergaard M, Czeizel AE, et al. (2007) Use of phenytoin, phenobarbital, or diazepam during pregnancy and risk of congenital abnormalities: a case-time-control study. Pharmacoepidemiol Drug Saf 16: 181-188. doi:10.1002/pds.1288. (Pubitemid 46291170)